Propylene Glycol Dilaurate (CAS 22788-19-8)
QUICK LINKS
Propylene glycol dilaurate is an ester compound formed by the esterification of propylene glycol with lauric acid, a medium-chain fatty acid. This compound is widely used in research to study its physicochemical properties and interactions within various formulations. The dual lauric acid chains confer hydrophobic characteristics, while the propylene glycol backbone provides hydrophilic properties, making it an effective surfactant and emulsifier. These amphiphilic properties are leveraged in the development and study of emulsions, microemulsions, and other colloidal systems. In research, propylene glycol dilaurate is utilized to investigate its role in stabilizing emulsions, enhancing the solubility of hydrophobic compounds, and modulating the release of active ingredients in formulations. Researchers explore its impact on the physical stability, viscosity, and rheological properties of various formulations, contributing to the optimization of product stability and performance. Overall, propylene glycol dilaurate serves as a valuable tool in formulation science and colloidal chemistry, aiding in the development and characterization of complex mixtures and delivery systems.
Propylene Glycol Dilaurate (CAS 22788-19-8) References
- Final report on the safety assessment of methoxyisopropanol and methoxyisopropyl acetate as used in cosmetics. | ,. 2008. Int J Toxicol. 27 Suppl 2: 25-39. PMID: 18830862
- Biosynthesis of medium chain length poly(3-hydroxyalkanoates) (mcl PHAs) from cosmetic co-products by Pseudomonas raguenesii sp. nov., isolated from Tetiaroa, French Polynesia. | Simon-Colin, C., et al. 2009. Bioresour Technol. 100: 6033-9. PMID: 19632827
- Self-nanoemulsifying drug delivery systems: formulation insights, applications and advances. | Date, AA., et al. 2010. Nanomedicine (Lond). 5: 1595-616. PMID: 21143036
- Transcutaneous delivery of leflunomide nanoemulgel: Mechanistic investigation into physicomechanical characteristics, in vitro anti-psoriatic and anti-melanoma activity. | Pund, S., et al. 2015. Int J Pharm. 487: 148-56. PMID: 25869452
- Self-emulsifying lipid formulation: an overview. | Saluja, V., et al. 2015. Curr Drug Deliv. 12: 166-76. PMID: 25911165
- Successful development of oral SEDDS: screening of excipients from the industrial point of view. | Nardin, I. and Köllner, S. 2019. Adv Drug Deliv Rev. 142: 128-140. PMID: 30414496
- Targeted and non-target screening of persistent organic pollutants and organophosphorus flame retardants in leachate and sediment from landfill sites in Gauteng Province, South Africa. | Sibiya, I., et al. 2019. Sci Total Environ. 653: 1231-1239. PMID: 30759563
- Zeta potential changing self-emulsifying drug delivery systems: A promising strategy to sequentially overcome mucus and epithelial barrier. | Nazir, I., et al. 2019. Eur J Pharm Biopharm. 144: 40-49. PMID: 31505225
- Effect of PGML excipient mixture in a transdermal system on the in vitro transport of estradiol across skin. | Irion, GD., et al. 1995. Pharm Res. 12: 1618-22. PMID: 8592659
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Propylene Glycol Dilaurate, 50 mg | sc-476854 | 50 mg | $380.00 |